341599 Sigma-AldrichFGF-10, Human, Recombinant
Recommended Products
Přehled
Replacement Information |
---|
Tabulka spec. kláve
Purity |
---|
≥97% by SDS-PAGE |
Product Information | |
---|---|
Form | Liquid |
Formulation | Lyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA. |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Biological activity | ED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells. |
Purity | ≥97% by SDS-PAGE |
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: <1.0 EU/µg protein |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Katalogové číslo | GTIN |
341599 | 0 |
Documentation
FGF-10, Human, Recombinant MSDS
Title |
---|
FGF-10, Human, Recombinant Certificates of Analysis
Title | Lot Number |
---|---|
341599 |
References
Přehled odkazů |
---|
Beenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235. Nomura, S., et al. 2008. Br. J. Cancer 99, 305. Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694. Beer, H.D., et al. 2005. Oncogene 24, 5269. Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11. Rice, R., et al. 2004. J. Clin. Invest. 113, 1692. Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39. Mailleux, A.A., et al. 2002. Development 129, 53. Sakaue, H., et al. 2002. Genes Dev. 16, 908. Makarenkova, H.P., et al. 2000. Development 127, 2563. Makarenkova, H.P., et al. 2000. Development 127, 2563. Pirvola, U., et al. 2000. J. Neurosci. 20, 6125. Weaver, M., et al. 2000. Development 127, 2695. Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230. Min, H., et al. 1998. Genes Dev. 12, 3156. Bellusci, S., et al. 1997. Development 124, 4867. Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191. |